23079470|t|Effects of alpha7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.
23079470|a|Agonists and positive allosteric modulators (PAMs) of alpha7 nicotinic acetylcholine receptors (nAChRs) are currently being considered as novel therapeutic approaches for managing cognitive deficits in schizophrenia and Alzheimer's disease. Though alpha7 agonists were recently found to possess antinociceptive and anti-inflammatory properties in rodent models of chronic neuropathic pain and inflammation, the effects of alpha7 nAChRs PAMs on chronic pain and inflammation remain largely unknown. The present study investigated whether PAMs, by increasing endogenous cholinergic tone, potentiate alpha7 nAChRs function to attenuate inflammatory and chronic neuropathic pain in mice. We tested two types of PAMS, type I (NS1738) and type II (PNU-120596) in carrageenan-induced inflammatory pain and chronic constriction injury (CCI) neuropathic pain models. We found that both NS1738 and PNU-120596 significantly reduced thermal hyperalgesia, while only PNU-120596 significantly reduced edema caused by a hind paw infusion of carrageenan. Importantly, PNU-120596 reversed established thermal hyperalgesia and edema induced by carrageenan. In the CCI model, PNU-120596 had long-lasting (up to 6 h), dose-dependent anti-hyperalgesic and anti-allodynic effects after a single injection, while NS1738 was inactive. Systemic administration of the alpha7 nAChR antagonist MLA reversed PNU-120596's effects, suggesting the involvement of central and peripheral alpha7 nAChRs. Furthermore, PNU-120596 enhanced an ineffective dose of selective agonist PHA-543613 to produce anti-allodynic effects in the CCI model. Our results indicate that the type II alpha7 nAChRs PAM PNU-120596, but not the type I alpha7 nAChRs PAM NS1738, shows significant anti-edematous and anti-allodynic effects in inflammatory and CCI pain models in mice.
23079470	11	17	alpha7	Gene	16404
23079470	52	58	murine	Species	10090
23079470	59	71	inflammatory	Disease	MESH:D007249
23079470	76	100	chronic neuropathic pain	Disease	MESH:D009437
23079470	289	307	cognitive deficits	Disease	MESH:D003072
23079470	311	324	schizophrenia	Disease	MESH:D012559
23079470	329	348	Alzheimer's disease	Disease	MESH:D000544
23079470	357	363	alpha7	Gene	16404
23079470	429	441	inflammatory	Disease	MESH:D007249
23079470	473	497	chronic neuropathic pain	Disease	MESH:D009437
23079470	502	514	inflammation	Disease	MESH:D007249
23079470	553	565	chronic pain	Disease	MESH:D059350
23079470	570	582	inflammation	Disease	MESH:D007249
23079470	742	754	inflammatory	Disease	MESH:D007249
23079470	759	783	chronic neuropathic pain	Disease	MESH:D009437
23079470	787	791	mice	Species	10090
23079470	816	820	PAMS	Chemical	MESH:C028797
23079470	830	836	NS1738	Chemical	MESH:C523981
23079470	851	861	PNU-120596	Chemical	MESH:C508388
23079470	866	877	carrageenan	Chemical	MESH:D002351
23079470	886	903	inflammatory pain	Disease	MESH:D010146
23079470	908	935	chronic constriction injury	Disease	MESH:D020208
23079470	937	940	CCI	Disease	MESH:D020208
23079470	942	958	neuropathic pain	Disease	MESH:D009437
23079470	986	992	NS1738	Chemical	MESH:C523981
23079470	997	1007	PNU-120596	Chemical	MESH:C508388
23079470	1030	1050	thermal hyperalgesia	Disease	MESH:D006930
23079470	1063	1073	PNU-120596	Chemical	MESH:C508388
23079470	1096	1101	edema	Disease	MESH:D004487
23079470	1135	1146	carrageenan	Chemical	MESH:D002351
23079470	1161	1171	PNU-120596	Chemical	MESH:C508388
23079470	1193	1213	thermal hyperalgesia	Disease	MESH:D006930
23079470	1218	1223	edema	Disease	MESH:D004487
23079470	1235	1246	carrageenan	Chemical	MESH:D002351
23079470	1255	1258	CCI	Disease	MESH:D020208
23079470	1266	1276	PNU-120596	Chemical	MESH:C508388
23079470	1327	1339	hyperalgesic	Disease	MESH:D006930
23079470	1349	1358	allodynic	Disease	
23079470	1399	1405	NS1738	Chemical	MESH:C523981
23079470	1451	1463	alpha7 nAChR	Gene	11441
23079470	1488	1498	PNU-120596	Chemical	MESH:C508388
23079470	1591	1601	PNU-120596	Chemical	MESH:C508388
23079470	1652	1662	PHA-543613	Chemical	MESH:C513163
23079470	1679	1688	allodynic	Disease	
23079470	1704	1707	CCI	Disease	MESH:D020208
23079470	1767	1770	PAM	Chemical	-
23079470	1771	1781	PNU-120596	Chemical	MESH:C508388
23079470	1816	1819	PAM	Chemical	-
23079470	1820	1826	NS1738	Chemical	MESH:C523981
23079470	1851	1860	edematous	Disease	MESH:D004487
23079470	1870	1879	allodynic	Disease	
23079470	1891	1903	inflammatory	Disease	MESH:D007249
23079470	1908	1911	CCI	Disease	MESH:D020208
23079470	1912	1916	pain	Disease	MESH:D010146
23079470	1927	1931	mice	Species	10090
23079470	Negative_Correlation	MESH:C508388	MESH:D002351
23079470	Negative_Correlation	MESH:C508388	MESH:D010146
23079470	Association	MESH:D007249	16404
23079470	Positive_Correlation	MESH:C508388	MESH:C513163
23079470	Positive_Correlation	MESH:D002351	MESH:D010146
23079470	Negative_Correlation	MESH:C523981	MESH:D006930
23079470	Negative_Correlation	MESH:C508388	MESH:D009437
23079470	Association	MESH:D009437	16404
23079470	Comparison	MESH:C508388	MESH:C523981
23079470	Negative_Correlation	MESH:C508388	MESH:D006930
23079470	Negative_Correlation	MESH:C508388	MESH:D004487
23079470	Negative_Correlation	MESH:C508388	MESH:D020208
23079470	Positive_Correlation	MESH:D002351	MESH:D004487

